Page last updated: 2024-10-21

hydroxyindoleacetic acid and Diabetic Nephropathies

hydroxyindoleacetic acid has been researched along with Diabetic Nephropathies in 1 studies

(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, J1
Suzuki, E1
Tajima, Y1
Takami, K1
Horikawa, Y1
Takeda, J1

Other Studies

1 other study available for hydroxyindoleacetic acid and Diabetic Nephropathies

ArticleYear
Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2
    Endocrine journal, 2016, Volume: 63, Issue:1

    Topics: Aged; Albuminuria; Ankle Brachial Index; Blood Flow Velocity; Case-Control Studies; Diabetes Mellitu

2016